Inventor · disambiguated record
Dennis Gately
Also filed as: GATELY DENNIS · GATELY DENNIS P
7 granted patents·6 pending applications·54 citations·filing 1996–2023
83Inventor score
Files withBIOGEN IDEC INC3MERCK SHARP & DOHME3RES DEV FOUNDATION3MERCK SHARP & DOHME LLC2IDEC PHARMA CORP1
Top patents by PatentIndex Score
13 records- 0194US10550190B2Phosphate based linkers for intracellular delivery of drug conjugatesMERCK SHARP & DOHME·Filed 2015·Granted Feb 4, 2020·13 cites·4 claims
- 0290US11773150B2Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 3, 2023·2 cites·7 claims
- 0384US11510993B2Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME·Filed 2016·Granted Nov 29, 2022·3 cites·20 claims
- 0469US2023099074A1Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0568US6344324B2Quantification of cellular injury using expression of a fluorescent protein under the control of the GADD153 promoterRES DEV FOUNDATION·Filed 2000·Granted Feb 5, 2002·12 cites·8 claims
- 0664US2024269303A1Cell targeting constructs and uses thereofRES FOUND DEV·Filed 2023·Application pending·0 cites
- 0763US2009053227A1Prostate Specific Genes and The Use Thereof in Design of TherapeuticsBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 0857US2003235533A1Prostate specific genes and the use thereof in design or therapeuticsIDEC PHARMA CORP·Filed 2003·Application pending·0 cites
- 0955US5770430ACellular injury response element and uses thereofRES DEV FOUNDATION·Filed 1996·Granted Jun 23, 1998·11 cites·16 claims
- 1054US2008213166A1Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon CarcinomasBIOGEN IDEC INC·Filed 2003·Application pending·0 cites
- 1147US6447997B1Gene coding for GADD153 as a clinical diagnostic and prognostic in cancer therapyRES DEV FOUNDATION·Filed 1997·Granted Sep 10, 2002·13 cites·5 claims
- 1245US10800826B2Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 13, 2020·0 cites·10 claims
- 1343US2006089493A1Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomasBIOGEN IDEC INC·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →